Sargent Bickham Lagudis’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$417K Hold
3,274
0.03% 203
2022
Q3
$343K Buy
3,274
+26
+0.8% +$2.85K 0.03% 201
2022
Q2
$341K Buy
3,248
+24
+0.7% +$2.85K 0.03% 212
2022
Q1
$412K Sell
3,224
-97
-3% -$11.7K 0.03% 196
2021
Q4
$410K Buy
3,321
+1
+0% +$131 0.03% 186
2021
Q3
$472K Hold
3,320
0.04% 174
2021
Q2
$518K Hold
3,320
0.04% 167
2021
Q1
$516K Hold
3,320
0.05% 158
2020
Q4
$497K Buy
3,320
+165
+5% +$23.3K 0.05% 162
2020
Q3
$417K Hold
3,155
0.04% 156
2020
Q2
$366K Sell
3,155
-25
-0.8% -$2.88K 0.04% 157
2020
Q1
$312K Buy
3,180
+26
+0.8% +$3.41K 0.04% 167
2019
Q4
$458K Hold
3,154
0.05% 150
2019
Q3
$420K Hold
3,154
0.05% 143
2019
Q2
$360K Hold
3,154
0.04% 159
2019
Q1
$391K Buy
3,154
+1
+0% +$114 0.05% 162
2018
Q4
$318K Hold
3,153
0.04% 166
2018
Q3
$402K Hold
3,153
0.05% 151
2018
Q2
$341K Hold
3,153
0.04% 155
2018
Q1
$334K Hold
3,153
0.04% 157
2017
Q4
$369K Sell
3,153
-308
-9% -$34.8K 0.04% 158
2017
Q3
$393K Buy
3,461
+309
+10% +$35.7K 0.05% 156
2017
Q2
$393K Hold
3,152
0.05% 154
2017
Q1
$374K Hold
3,152
0.05% 158
2016
Q4
$316K Hold
3,152
0.05% 157
2016
Q3
$398 Sell
3,152
-771
-20% -$95.3K 0.06% 148
2016
Q2
$459K Hold
3,923
0.07% 140
2016
Q1
$406K Buy
+3,923
New +$379K 0.07% 146

Other funds holding ZBH

Sargent Bickham Lagudis's ZBH Position: Q4 2022 in Review

Sargent Bickham Lagudis held its Zimmer Biomet (ZBH) position steady in Q4 2022 at 3,274 shares worth $417K. The position accounts for 0.03% of the portfolio, ranked #203.

Sargent Bickham Lagudis first reported a position in ZBH in Q1 2016 and has held it in 28 quarters since. The position peaked at $518K in Q2 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

  • Sargent Bickham Lagudis held 3,274 shares of Zimmer Biomet worth $417K as of Q4 2022.
  • Sargent Bickham Lagudis left its Zimmer Biomet share count unchanged in Q4 2022.
  • Zimmer Biomet made up 0.03% of Sargent Bickham Lagudis's portfolio in Q4 2022, its #203 holding.
  • Sargent Bickham Lagudis first reported a position in Zimmer Biomet in Q1 2016 and has held it in 28 quarters since.
  • Sargent Bickham Lagudis's Zimmer Biomet position peaked at $518K in Q2 2021.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Sargent Bickham Lagudis's 13F filing for Q4 2022, filed 23 Jan 2023.